Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

Test your blood from the comfort of your home with Athelas

Add as a preferred source on Google

Blood testing startup Theranos may be dead in the water, but that doesn’t mean that the concept behind the disgraced startup has disappeared. Really, it has just found a new champion. Meet Athelas, heralded as an instant blood diagnostics system capable of testing for diseases such as the flu, bacterial infections, and even cancer. Best of all? You can do all your testing from the comfort of your own home.

Founded by Tanay Tandon when he was just 17, the three-year-old startup was initially intended to detect malaria via blood samples. But now, Tandon has expanded Athelas’ capabilities. The cylindrical device (which looks a bit like an Amazon Echo) allows you to insert a slide with a few drops of your blood, and then determines whether your white blood cell count is abnormal. Your results are delivered to you via a companion app, and should be viewable within 60 seconds.

Recommended Videos

Powered by computer imaging and developed in conjunction with oncologists (who are apparently already lending these devices to their patients), Athelas wants to avoid the nightmare that was the Elizabeth Holmes and Theranos debacle. Of course, it helps that the Athelas team is rife with medical expertise, and already enjoys clinical validation of its results. Moreover, Athelas is FDA-approved, and can be used for imaging diagnostics.

As it stands, the firm expects the device to be used mainly at home, but there are plans for hospitals to take advantage of the device for triage purposes. And apparently, there are partnerships with pharmaceutical companies brewing as well.

“One of our goals is to become a companion diagnostic for a lot of these interesting drugs,” Tandon told TechCrunch.

If you’re interested in trying out an Athelas for yourself, you can either talk to a doctor about potentially acquiring a rental unit, or you can buy an Athelas straight from the the company’s website. For $20 a month, you’ll be able to take 10 tests and hopefully “flag bacterial infections, monitor Neutropenia, and generate White Blood Cell markers.” The device is set to begin shipping on September 28, 2017, and the company promises not to charge customers until they receive their Athelas.

Lulu Chang
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more